[TREATMENT OF DECALCIFYING OSTEOPATHIES WITH A NEW ANABOLIC AGENT: STANOZOLOL].
D045930:Anabolic Agents; D001847:Bone Diseases; D001859:Bone Neoplasms; D002127:Calcium Isotopes; D002128:Calcium Metabolism Disorders; D006801:Humans; D009101:Multiple Myeloma; D010018:Osteomalacia; D010024:Osteoporosis; D010760:Phosphorus Metabolism Disorders; D011874:Radiometry; D013197:Stanozolol; D013256:Steroids
D045930:Anabolic Agents; D002127:Calcium Isotopes; D013256:Steroids; D013197:Stanozolol
ANABOLIC STEROIDS; BONE DISEASES; BONE NEOPLASMS; CALCIUM ISOTOPES; CALCIUM METABOLISM DISORDERS; MULTIPLE MYELOMA; OSTEOMALACIA; OSTEOPOROSIS; PHOSPHORUS METABOLISM DISORDERS; RADIOMETRY
TRAITEMENT DES OST'EOPATHIES D'ECALCIFIANTES PAR UN NOUVEL ANABOLISANT: LE STANOZOLOL.